期刊文献+

IL-21对CTL抗非霍奇金淋巴瘤影响的研究 被引量:3

Study of interleukin - 21 on the anti - lymphoma activity of cytotoxic T lymphocytes in lymphoma
下载PDF
导出
摘要 目的:探讨白介素21(IL-21)对细胞毒T淋巴细胞(CTL)杀伤非霍奇金淋巴瘤(NHL)的影响,阐述该影响是通过IFN-γ和TNF-α的高表达而实现。方法:分选树突状细胞(DCs),用NHL细胞株(Raji)冲击,诱导产生CTL;将此培养液分为对照组和实验组,实验组加入100ng/ml的IL-21。ELISA、RT-PCR检测IFN-γ和TNF-α水平。结果:IL-21作用组,IFN-γ水平:469.32±2.83pg/ml,TNF-α:82.52±4.72pg/ml,对照组,IFN-γ水平:27.63±2.76pg/ml,TNF-α:11.63±1.54pg/ml,两组差异显著(P<0.05)。结论:IL-21是通过IFN-γ和TNF-α的高表达而实现增强CTL杀伤NHL的作用,有重要的临床意义。 Objective:To investigate the effect of interleukin-21 on the anti-lymphoma activity of cytotoxic T lymphocytes induced by dendritic cells in vitro,and clarify the mechanism of CTLs against lymphoma is the expression of IFN-γ and TNF-α by CTLs.Methods:DCs was seperated from healthy human peripheral blood mononuclear cells.DC was attacked by Raji to induce lymphoma-specific CTL.Then the culture fluid was divided into control group and treatment group.The treatment group was given IL-21(100ng / ml).IFN-γ and TNF-α level in culture supernatant were determined by ELISA.Transcript expression of IFN-γ and TNF-α were detected by RT PCR.Results:After IL-21 acting on the CTL,IFN-γ level in the supernatant was 469.32 ± 2.83 pg / ml,and TNF-α was 82.52 ± 4.72pg / ml;no IL-21 acting group,IFN-γ was 27.63 ± 2.76pg / ml,TNF-α was 11.63 ± 1.54pg / ml,(P 0.05).RT-PCR results were the same.Conclusion:IL-21 can increase IFN-γ and TNF-α production in CTL to enhance it's anti-lymphoma effect.These results suggest that IL-21 have a potential applications in clinic.
出处 《现代肿瘤医学》 CAS 2012年第3期605-607,共3页 Journal of Modern Oncology
关键词 非霍奇金淋巴瘤 白介素21 树突状细胞 细胞毒T淋巴细胞 细胞免疫治疗 lymphoma IL-21 dendritic cells cytotoxic T lymphocyte cellular immunotherapy
  • 相关文献

参考文献8

二级参考文献60

共引文献52

同被引文献17

  • 1Rankin A L, Macledo H, Keegan S,etal. IL-21 recep- tor in crictica] for the development of memory B cell responses[J]. J Immunol,2011,186(2) :667- 674.
  • 2Imtiyaz,H. Z. et al. Hypoxia-inducible factor 2a regu- lates macrophage ruction in mouse models of acute and tumor inflammation[J]. J. Clin. Invest,2010,120 : 2699- 2714.
  • 3Spolski R, Lenard W J. The Yin and Yang of interleu- kin-2] in allergy, autoinmmunity and cancer[J]. Curr Opin Immunol, 2008,20 ( 3 ) : 295-301.
  • 4Lenard W J. Interleukin-21 :basic biology and implica- tions for cancer and autoimmunity[J]. Annu Rev Im- munol,2008,26:57-79.
  • 5Monteleone G, Pallone F, Macdonale TT. Interleukin- 21 :a critical regulator of the balance between effector and regulatory T cell resposes[J]. Trends Immunol, 2008,29(6) :290-294.
  • 6Kanagawa N, Gao JQ, Motomura Y, et al. Antitu- mor mechanism of intratumoral injection with IL-12- expressing adenviral vetor against IL-12-unreponsive tumor[J]. Biochem and Biophys Res Commun, 2008, 372(4) :821-825.
  • 7Gaspar VM, Moreira AF, Costa EC, et al. Gas-gen- erationg TPGS-PLGA microspheres loaded with nano particles (NIMPS) for codelivery of minicircle DNA and anti-tumoral drugs [J]. Colloids Surf B Biointer- faces,2015,7(9):287- 294.
  • 8Venkatesh DN, Reddy AK, Samanta MK, et al. De velopment and in vitro evaluation of colonic drug deliv- ery systems for tegaserod maleate[J]. Asian J Pharm, 2009,3(1) :50-53.
  • 9李澜,刘铁强,刘志青,刘广贤,艾辉胜.IL-21单独或联合IL-15/IL-2对G-CSF动员人外周血单个核细胞体外增殖和抗肿瘤活性作用研究[J].中国实验血液学杂志,2008,16(2):350-354. 被引量:7
  • 10许芝彬,赵文昌,宋丽军,陈小玲,蔡晓铁,梁清霞,吴宗文.药用薄膜包衣材料的研究新进展[J].中国医药导报,2011,8(8):11-13. 被引量:15

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部